Esperion Therapeutics | ESPR - Trade Creditors


Esperion Therapeutics reported $65.07M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alnylam Pharmaceuticals USD 126.63M 10.91M Mar/2026
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Amarin USD 48.15M 2.8M Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Cipla INR 30.35B 1.98B Sep/2025
CSL USD 3.17B 290M Dec/2025
Cytokinetics USD 24.71M 80.91M Mar/2026
Daiichi Sankyo JPY 568.5B 16.84B Dec/2025
Eli Lilly USD 5.03B 350M Mar/2026
Esperion Therapeutics USD 65.07M 12.44M Dec/2025
Geron USD 11.26M 146K Dec/2025
Grifols EUR 987.75M 47.87M Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
Merck USD 3.86B 541M Mar/2026
Minerva Neurosciences USD 640K 305K Dec/2025
Moderna USD 161M 156M Mar/2026
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Pfizer USD 4.51B 734M Mar/2026
PTC Therapeutics USD 45.49M 8.87M Dec/2025
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Sanofi EUR 22.71B 219M Mar/2026
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
United Therapeutics USD 7.1M 460.9M Dec/2025
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024